Article Details

Harpoon Therapeutics Presents Interim Clinical Data from its Ongoing Phase 1/2 Study and ...

Retrieved on: 2021-12-12 02:29:52

Tags for this article:

Click the tags to see associated articles and topics

Harpoon Therapeutics Presents Interim Clinical Data from its Ongoing Phase 1/2 Study and .... View article details on hiswai:

Excerpt

... novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases.

Article found on: www.kulr8.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up